Figure legends:
Figure 1. Flow chart of literature search and selection.
Figure 2. Forest plots for the safety of any adverse event.
AEs: adverse events; ESAs:
erythropoiesis-stimulating agents; RR: risk ratio; 95% CI: 95%
confidence interval.
Figure 3. Forest plots for the safety of any serious adverse event.
SAEs: serious adverse events; ESAs: erythropoiesis-stimulating agents;
RR: risk ratio; 95% CI: 95% confidence interval.
Figure 4. Forest plots for the safety of the treatment-emergent adverse
events.
The risk ratio of cardiovascular events, vascular-access complications,
hypertension, gastrointestinal disorder, hyperkalemia, and cancer. ESAs:
erythropoiesis-stimulating agents; RR: risk ratio; 95% CI: 95%
confidence interval.
Figure 5. Forest plots for the
safety of the treatment-emergent adverse events.
The risk ratio of pneumonia, upper respiratory tract infection,
nasopharyngitis, urinary tract infection, hypotension, and muscle spasms
are displayed separately. ESAs: erythropoiesis-stimulating agents; RR:
risk ratio; 95% CI: 95% confidence interval.
Figure 6. Forest plots for the efficacy of Hb response.
ESAs: erythropoiesis-stimulating agents; RR: risk ratio; 95% CI: 95%
confidence interval.